XTAE
AMDA
Market cap12mUSD
Jul 20, Last price
250.90ILS
1D
-0.71%
1Q
29.80%
IPO
3,120.80%
Name
Almeda Ventures LP
Chart & performance
P/E
—
P/S
—
EPS
0.13
Div yield, %
—
Shrs. gr., 5y
43.36%
Rev. gr., 5y
%
Revenues
88k
P
Net income
2m
P
CFO
-1m
L-2.28%
Dividend
May 28, 202629.9035 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Almeda Ventures Limited Partnership, established in Tel Aviv, Israel, in 2020, functions as a venture capital firm. The partnership strategically deploys capital across various development stages, including seed, startup, early-stage, and established middle-market companies. Its core investment thesis centers on health technology innovation, with a particular emphasis on medical devices, digital health solutions, bio-convergence, and public R&D collaborations. Additionally, Almeda Ventures allocates funds to life sciences research and development enterprises. Geographically, the firm primarily focuses its investments within Israel, the United States, and Europe.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |